Ad
related to: AACR
Search results
Allogene secures $15 million grant for cancer trial By Investing.com
Investing.com· 7 hours agoThe funding is earmarked to support the Phase 1 TRAVERSE trial, which is evaluating the safety and...
Has Immunotherapy Found Its Place in Pancreatic Cancer?
Medscape· 5 days agoA new study suggested that adding nivolumab to neoadjuvant treatment improves outcomes in patients...
ESMO Recap: Adjuvant Vs. Neoadjuvant Therapy in Melanoma
Medscape· 2 days agoToday, I'll be reporting on a couple of abstracts related to adjuvant and neoadjuvant therapy in...
AstraZeneca drops GOLDILOX and the porcupine in R&D update
FierceBiotech· 2 days agoAstraZeneca’s first-quarter results (PDF) put a twist on a fairy tale, telling the lesser-known...
If You Were Born After 1965, Your Cells Might Be Aging Faster
Verywell Health via Yahoo News· 3 days agoResearch suggests that accelerated aging is linked to higher rates of early-onset cancers. Longevity...
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023...
Morningstar· 4 days agoSAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate ...
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
Morningstar· 2 days agoGlobal licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel radioenhancer NBTXR3Prolonged survival in Study ...
GV20 Therapeutics Announces Publication in Cell Highlighting the Discovery of IGSF8 as an Innate...
FOX 8 Cleveland· 2 days agoGV20 Therapeutics, a clinical-stage biotechnology company integrating AI, genomics, and cancer biology to create next-generation antibody therapeutics, today announced the publication of a peer-reviewed ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 5 days agoNew York, USA, April 22, 2024 (GLOBE NEWSWIRE) -- EGFR Inhibitor Market to Accelerate Substantially During the Study Period (2020–2034) | DelveInsight According to DelveInsight’s analysis, the growth of the EGFR inhibitor market is expected
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 1 day agoPress release PEP-Therapy and Institut Curie Announce First Patients Dosedin Phase Ib Clinical Trial Evaluating PEP-010in Ovarian and Pancreatic Cancers Paris (France), April 25, 2024 – PEP-Therapy, a clinical-stage biotechnology company developing
